Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
McKesson
Dow
AstraZeneca
Harvard Business School

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202107


Email this page to a colleague

« Back to Dashboard

NDA 202107 describes KORLYM, which is a drug marketed by Corcept Therap and is included in one NDA. There are sixteen patents protecting this drug and one Paragraph IV challenge. Additional details are available on the KORLYM profile page.

The generic ingredient in KORLYM is mifepristone. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the mifepristone profile page.
Summary for 202107
Tradename:KORLYM
Applicant:Corcept Therap
Ingredient:mifepristone
Patents:16
Formulation / Manufacturing:see details
Paragraph IV (Patent) Challenges for 202107
Tradename Dosage Ingredient NDA Submissiondate
KORLYM TABLET;ORAL mifepristone 202107 2017-12-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:Feb 17, 2012TE:ABRLD:Yes
Patent:⤷  Free Forever TrialPatent Expiration:Aug 12, 2036Product Flag?Substance Flag?Delist Request?
Patented Use:TREATING CUSHING'S SYNDROME
Patent:⤷  Free Forever TrialPatent Expiration:Jan 18, 2037Product Flag?Substance Flag?Delist Request?
Patented Use:TREATING CUSHING'S SYNDROME
Patent:⤷  Free Forever TrialPatent Expiration:Apr 20, 2036Product Flag?Substance Flag?Delist Request?
Patented Use:TREATING CUSHING'S SYNDROME

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
McKesson
Medtronic
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.